Desk-sized fusion reactors could solve medical isotope crisis for cancer diagnosis
Astral Systems, a UK startup, aims to address the medical isotope shortage with desk-sized fusion reactors using multistate fusion technology. The company secured £4.5M to commercialize its approach, which promises more efficient and cost-effective isotope production than traditional reactors, potentially improving cancer diagnosis and treatment accessibility.